Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-14

FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Tranylcypromine sulfate by Strides Pharma Science Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranylcypromine sulfate (Tranylcypromine sulfate)

Snippet

SUPPL AP for TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE)